Actuate Therapeutics, Inc. (ACTU): Insider Trading, Congress Trades & Research | Tormere

ACTU

$0.39+2.09%visit website

ACTUATE THERAPEUTICS, INC.

Market Cap

$9M

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.25

25mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Price / TTM revenue

P/B

9.5

Price / stockholders equity

EV/EBITDA

—

TTM, op-income proxy

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	2,178	2,130	2,565	2,067	8,940
Total operating expenses	5,472	4,688	5,706	4,907	20,773
Operating income	(5,472)	(4,688)	(5,706)	(4,907)	(20,773)
Interest expense	5.1	5.1	5.1	5.1	20.3
Net income	(5,407)	(4,554)	(5,626)	(4,867)	(20,454)
EPS (basic) ($)	(0.25)		(0.24)	(0.20)	(0.87)
EPS (diluted) ($)	(0.25)		(0.24)	(0.20)	(0.87)
Weighted avg. shares (basic)	21,395		23,537	23,872
Weighted avg. shares (diluted)	21,395		23,537	23,872

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 9 more quarters, back to Jun 2023, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Actuate Therapeutics Raises $9.96 Million in Stock-and-Warrant Offering

TradingView · 2026-10-28

Two shares and a warrant sold for $0.71 as Actuate Therapeutics (ACTU) closed its offering.

Stock Titan · 2026-10-28

Top Market Movers: US Gainers and Losers for October 27, 2026

ChartMill · 2026-10-27

Premarket Movers: Gainers and Losers Ahead of Today's US Open

ChartMill · 2026-10-27

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 2026-10-27

Actuate Therapeutics prices $11M public offering of stock and warrants

TradingView · 2026-10-27

Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering

Yahoo · 2026-10-27

Two shares and an option to buy another are priced at 71 cents in Actuate's offering.

Stock Titan · 2026-10-27

Nasdaq Gains Over 150 Points; Coca-Cola Posts Upbeat Earnings

Benzinga · 2026-10-27

Actuate Therapeutics Prices ~$11M Offering Of 30,986M Common Shares, Warrants At $0.71 Per Unit

Benzinga · 2026-10-27

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 2026-10-27

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga · 2026-10-19

Why XCF Global Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-19

Postmarket Movers for Oct. 16, 2026: BitFuFu, Zone Frontier Among Gainers; ATA Creativity, Zhibao Among Losers

ChartMill · 2026-10-16

Top Movers in Today's US Session: Biggest Gainers and Losers

ChartMill · 2026-10-16

Informational purposes only, not investment advice.